The ADV-G isolate of Aleutian mink disease parvovirus (ADV) replicates permissively in Crandell feline kidney (CRFK) cells but is nonpathogenic for mink, whereas the highly pathogenic ADV-Utah isolate is nonviable in CRFK cells. To assign control of host range in CRFK cells and pathogenicity to specific regions of the ADV genome, we constructed a full-length molecular clone chimeric between ADV-G and ADV-Utah. If either the map unit (MU) 54±65 (clone G/U-5) or MU 65±88 (clone G/U-7) sections were ADV-Utah, viability in CRFK cells was abolished, thus indicating that in vitro host range was controlled by two independent determinants: A in the MU 54±65 segment and B in the MU 65±88 segment. Determinant B could be divided into two subregions, B1 (MU 65±69) and B2 (MU 73±88), neither of which alone could inhibit replication in CRFK cells, an observation suggesting that expression of the B determinant required interaction between noncontiguous sequences. Adult mink of Aleutian genotype inoculated with G/U-8 or G/U-10 developed viremia, antiviral antibody, and histopathological changes characteristic of progressive Aleutian disease. The capsid sequences of G/U-8 and G/U-10 differed from ADV-G at five and four amino acid residues, respectively. Our results suggested that the host range and pathogenicity of ADV are regulated by sequences in the capsid protein gene.
INTRODUCTION
Aleutian mink disease parvovirus (ADV) causes disease in both adult and newborn mink . Aleutian disease (AD) in adult mink is characteristically a persistent infection accompanied by a severe disorder of the immune system. Affected animals have a chronic viremia, high levels of antiviral antibody, progressive hypergammaglobulinemia, immune complex glomerulonephritis, enlargement of lymphoid organs, and massive infiltration of liver and kidney with lymphocytes and plasma cells Eklund et al., 1968; Porter, 1986) . Newborn mink, on the other hand, classically develop a fulminant interstitial pneumonia that results in death from respiratory distress by 2 weeks of age . However, milder forms of both the adult and newborn disease Bloom et al., 1994; Hadlow et al., 1983) , as well as inapparent infections (An and Ingram, 1977, 1978) , are also described. Thus there exists a broad spectrum of severity in ADV infection.
Although host factors, such as age, immune status, and genotype, play a significant role in determining the outcome of ADV infection, the variability in disease severity is indisputably regulated by viral determinants (Bloom et al., 1980 Oie et al., 1996) . Highly virulent isolates of virus, such as ADV-Utah and ADV-TR, cause severe disease in adult and newborn mink Oie et al., 1996) with mortality rates approaching 100% in both Aleutian and non-Aleutian genotypes. At the other end of the spectrum from ADVUtah and ADV-TR is ADV-G Bloom et al., 1980 Bloom et al., , 1990 . This isolate does not induce AD in adult mink and has reduced pathogenicity for mink kits Bloom et al., 1980; Oie et al., 1996) . Other isolates of ADV exhibit intermediate pathogenicity patterns (Hadlow et al., 1983 (Hadlow et al., , 1984 Oie et al., 1996) . In addition, ADV-G replicates permissively in Crandell feline kidney cells (CRFK) , whereas the pathogenic isolates are replication defective in the same cells Hahn et al., 1977) . Thus there are at least two biological characteristics encoded by the virus: one controls viable replication in CRFK cells (in vitro host range), and the other controls the ability to cause disease (pathogenicity).
Mapping of the viral sequence determinants that specify these characteristics has been greatly facilitated by the development of full-length molecular clones (Bloom et al., 1990 . Full-length constructs of ADV-G are viable when transfected into CRFK cell cultures, indicating that the determinant for in vitro host range is retained. The rescued virus does not induce antibody, viremia, or lesions typical of progressive AD, indicating that the pathogenicity determinant is not present in the molecularly cloned virus. Attempts to develop full-length constructs of ADV-Utah from infected mink tissues have been unsuccessful (Bloom et al., , 1990 , and we rely on the full-length ADV-G clone as a starting point for the analysis of sequences from ADV-Utah. When a large fragment of ADV-Utah [map unit (MU) 15±88], containing the bulk of the nonstructural and capsid proteins, is substituted into ADV-G, the resulting construct is nonviable in CRFK cells . Thus sequences regulating the in vitro host range are present in this portion of the genome, and this construct serves as a surrogate for ADV-Utah.
In previous efforts to localize more precisely the sequence determinants governing pathogenicity and in vitro host range, we prepared chimeric full-length clones containing regions of both ADV-G and ADV-Utah (G/U chimeras) . G/U chimeras containing both large regions of the ADV-Utah nonstructural proteins and several regions of the capsid protein yield virus when transfected into CRFK cells. However, any construction containing the ADV-Utah MU 54±65 fragment of the capsid gene does not replicate in vitro. In addition, substitution of the ADV-G MU 54±65 fragment into a nonviable G/U chimera restores viability. Thus a determinant of in vitro host range for CRFK cells is present in the MU 54±65 segment. Furthermore, none of the chimeric viruses from our previous study induce anti-ADV antibody, viremia, or clinical disease, suggesting that the pathogenicity determinant is not present in any of these molecular constructs.
In the present work, we constructed additional fulllength chimeric molecular clones to identify portions of the ADV capsid proteins that regulate CRFK host range and pathogenicity. Replication of ADV in CRFK cells was regulated by two independent regions within the capsid protein gene. In addition, two recombinant viruses that contained overlapping sections of ADV-Utah VP2 capsid protein induced viremia, anti-ADV antibody, and pathological changes typical of progressive disease.
RESULTS
In our previous study, we mapped a host range determinant for CRFK replication or viability to the MU 54±65 region of VP2 (denoted A in Fig. 4) ; that is, any G/U chimera carrying the A region from ADV-Utah (e.g., G/U-2, G/U-5) cannot replicate in vitro in CRFK cells (Fig. 1) . However, we were concerned that the presence of the inhibitory ADV-Utah A region might have obscured the effect of other capsid sequences on viability in CRFK cells or pathogenicity. Consequently, we prepared additional G/U chimeras (Fig. 1) to define more precisely the capsid sequences controlling ADV replication and pathogenicity.
Chimeras G/U-6 and G/U-7 were constructed to analyze the role of ADV-Utah capsid sequences in the presence of the viable A region from ADV-G (Fig. 1) . Both G/U-6 and G/U-7 were nonviable, indicating that a sequence in ADV-Utah MU 65±88 segment was able to FIG. 1. Schematic of VP2 capsid sequences contained in chimeric ADV constructs. The VP2 portions of the chimeric ADV molecular clones described in this study were schematically aligned, indicating the initiation (VP2 ATG, NT 2406, MU 51) and termination (VP2 TAA, NT 4347, MU 92). The extent of the ADV-Utah sequence (black area) and the MU locations defining the bounds of the various constructs are depicted. The titer in CRFK cells (FFU/ml) and the pathogenicity for mink of virus stocks rescued from viable plasmids are shown. As noted in the text, G/U-8 also contained the MU 15±30 portion of ADV-Utah, not contained within the capsid gene region.
abrogate replication in vitro even in the presence of the viable A region from ADV-G. This result mapped a determinant, denoted B, to the MU 65±88 region. Consequently, there were two separate determinants contained within the capsid proteins that independently controlled CRFK host range or viability: A (MU 54±65) and B (MU 65±88).
Our earlier constructs G/U-9 and G/U-11 contain portions of the ADV-Utah B region yet are viable in CRFK cells ( Fig. 1) . This observation suggested that the CRFK host range determinant B might not be a simple contiguous linear sequence. To examine this possibility, we made chimeras G/U-8 (ADV-Utah MU 69± 88) and G/U-10 (ADV-Utah MU 73±88) (Fig. 1) . Both of these new clones were also viable in CRFK cells, suggesting that the inhibitory B element could indeed be divided into two sections, neither of which alone was sufficient to render a construct nonviable for CRFK cells. Therefore, it appeared that expression of the inhibitory B host range determinant required the presence of two noncontiguous sequences. It was likely that one element (B1) was present within MU 65±69 and the other (B2) was present within MU 73±88.
Several additional new clones were also nonviable ( Fig. 1 ): G/U-1 (the entire ADV-Utah capsid gene), G/U-3 (ADV-Utah capsid from MU 54±88), and G/U-4 (ADV-Utah capsid from VP2 start to MU 73). These findings confirmed previous results that the presence of both the A and B regions from ADV-Utah in the same construct do not allow for constitution of a viable virus in CRFK cells.
None of our previous viable clones showed infectivity in mink . We wanted to determine whether the G/U-8 and G/U-10 were replication competent in mink. Therefore, Aleutian mink were inoculated with 10 5 fluorescence-forming units (FFU) of virus and tested for the development of anti-ADV antibodies and viremia (measured by PCR on serum) (Fig. 2) (Oie et al., 1996) . As controls, parallel groups were mock infected or inoculated with ADV-G or ADV-Utah. All five mink inoculated with G/U-8 developed antibody, and the geometric mean titer at 90 days p.i. was 151. Three of these mink had detectable viremia at some point, and in two of the five mink, the viremia persisted. All five mink inoculated with G/U-10 also developed antibody, but the geometric mean titer at 90 days p.i. was 12; three of them had transient viremia at 10 days p.i. The ADV-Utah-infected mink developed persistent viremia and high titers of anti-ADV antibodies (geometric mean titer at 90 days p.i. was 256). The mock-and ADV-G-infected mink developed neither detectable viremia nor antiviral antibody. Thus in contrast to ADV-G and our earlier chimeric viruses , both G/U-8 and G/U-10 showed clear evidence of in vivo viral replication and antibody induction.
Another feature of progressive AD is an elevation of serum ␥-globulin levels, and the ADV-Utah-infected mink developed marked increases (32% mean) Eklund et al., 1968; Porter, 1986) . The mean ␥-globulin elevation in the five G/U-8 mink was 4.8%, but three individual values of 10%, 12%, and 11% were noted. The mean ␥-globulin elevation in the G/U-10 group was 7.6%, but one animal developed pronounced hypergammaglobulinemia (28% increase). The mock and ADV-G groups had mean elevations of 0.6% and 2.4%, respectively. Thus chimeras G/U-8 and G/U-10 were capable of inducing ␥-globulin elevations in some, but not all, infected mink.
Finally, tissues collected from the mink at the time of death (ϳ120 days p.i.) were examined microscopically (Fig. 3) . The ADV-Utah mink developed classic signs of severe AD (Eklund et al., 1968; Helmboldt and Jungherr, 1958) (Figs. 3e±h) . The livers had collections of lymphocytes and plasma cells in the portal areas and in numerous foci within the lobules (Fig. 3e) . The kidneys had massive interstitial infiltrates of lymphocytes and plasma cells involving both tubules and glomeruli (Fig. 3f) . In addition, hypercellularity, obliteration of capillary loops, and an obvious increase in the mesangial matrix of the glomeruli were evident (Fig. 3f) . The mesenteric lymph nodes had moderate hyperplasia and plasmacytosis in the medullary cords, including Russell bodies (Figs. 3g  and 3h ). Mink infected with both G/U-8 (two of five) (Figs. 3i±l) and G/U-10 (three of five) (Figs. 3m±p) also showed pathological alterations characteristic of typical progressive AD, although they were less widespread than those seen in the ADV-Utah mink. Neither the glomerular lesions nor interstitial infiltrates in the kidneys were as pronounced (Figs. 3j and 3n) . A single animal inoculated with ADV-G had minimal changes consisting of slight portal infiltrate and scant interstitial kidney infiltrates (not shown). Mock-infected animals had none of these changes (Figs. 3a±d) .
DISCUSSION
These experiments have provided important information on two aspects of ADV infections. First, we have shown that viruses rescued from some chimeric molecular clones of ADV can replicate to detectable levels in vivo and can cause AD. Second, the results have mapped in more detail the host range determinants of the ADV genome that govern permissive replication in vitro.
Two chimeric viruses (G/U-10 and G/U-8) induced viremia and antiviral antibody in adult Aleutian genotype mink (Fig. 2) . Furthermore, several mink inoculated with these viruses developed progressive disease (Fig. 3 ) Eklund et al., 1968) . These are the first molecularly cloned ADV preparations to be frankly patho- genic for mink, and it will now be possible to study viral pathogenesis with a molecularly derived virus of precisely defined sequence. Previous pathogenesis studies have used virus prepared from infected animals, and in vivo derived virus is coated with antiviral antibody Porter and Larsen, 1967) . Antibody enhances ADV infection of phagocytic target cells and restricts both in vivo and in vitro infection Bloom et al., 1994; Dworak et al., 1997; Kanno et al., 1993) . Furthermore, the use of antibody-coated virus might mask other primary target cells, such as type 2 alveolar cells in which the virus replicates permissively in the absence of antibody . Thus the use of in vivo derived ADV may have altered the initial virus±animal host interactions, and these concerns will be obviated by using pathogenic chimeric viruses.
The pathogenic molecular constructs G/U-8 and G/U-10 were based on ADV-G but contained VP2 capsid sequences from ADV-Utah. In previous studies, we examined the VP2 sequences from a number of in vivo pathogenic isolates of ADV Gottschalk et al., 1991; Oie et al., 1996) . To identify amino acid residues that might be unique to pathogenic ADV isolates, we aligned the VP2 sequences of G/U-8 and G/U-10 with ADV-G, ADV-Utah, and three other in vivo pathogenic isolates: ADV-TR, ADV-Pullman, and the Danish ADV-ZK8 (Fig. 4) Gottschalk et al., 1991; Oie et al., 1996) . Only two residues (Q at VP2 position 395 and D at VP2 position 534) were unique to all the pathogenic viruses, including G/U-8 and G/U-10. In addition, G/U-10 had an isoleucine residue (I) at position 352, whereas G/U-8 and the in vivo isolates had valine (V). There are two other positions, 434 and 491, at which most of the in vivo isolates vary from ADV-G (Oie et al., 1996) . If some or all of these variant residues were responsible for conferring pathogenicity, the effect must be mediated by a very few amino acids. Finally, G/U-8 and G/U-10 were not as uniformly or as severely pathogenic as ADV-Utah, a variability noted with some in vivo isolates of ADV (Hadlow et al., 1983; Oie et al., 1996) . Site-directed mutagenesis studies, which are under way, will enable us to examine the role of the specific capsid residues and determine whether pathogenicity can be increased by selective changes.
Two regions of VP2 independently regulated the ability of full-length molecular clones to replicate in CRFK cells (Fig. 4) . Determinant A is located within the MU 54±65 segment of VP2, a section in which there are only three amino acids that consistently differ between ADV-G and viruses that are nonviable for CRFK (Oie et al., 1996) . The second determinant, B, is more complex, and its expression required cooperative interactions between the two subregions B1 and B2. The most likely explanation is that there are tertiary interactions between nonadjacent amino acids in B1 and B2. Determinant B1 contains the hypervariable region of VP2. However, because both sequence types of this region (T. . .T.DAV and Q. . .E.TGT) (Fig. 4) Oie et al., 1996) can exist in CRFK-viable constructs, the residues in B1 that interact with B2 to control host range may not be the hypervariable ones. The B2 segment also contains a limited number of amino acids divergent between pathogenic and nonpathogenic constructions (Fig. 4) . In addi- tion, the ADV-Utah B2 was contained in the two pathogenic molecular clones: G/U-8 and G/U-10 (Fig. 4) . Studies in progress will attempt to determine whether the same residues regulate host range and pathogenicity. These experiments will be enhanced by structural studies to localize specific residues within the virion structure (Agbandje et al., 1995) .
The mechanism by which capsid sequences might regulate ADV host range for CRFK is obscure, but the fact that intact capsid proteins are detected after primary transfection with nonviable plasmids indicates that the block is not simply failed synthesis . Perhaps the capsid proteins of the nonviable plasmids are incapable of assembling into particles, a hypothesis that is testable using expression in recombinant baculoviruses Wu et al., 1994) . Alternatively, the defect might be in capsid protein transport, receptor recognition, or genome encapsidation functions (Ball-Goodrich and Tattersall, 1992; Previsani et al., 1997; Strassheim et al., 1994; Truyen and Parrish, 1992) . In addition, it is conceivable that virus might be produced after the initial round of transfection but be incapable of initiating subsequent rounds of infection (Gardiner and Tattersall, 1988; Tattersall and Bratton, 1983) .
Capsid proteins of a variety of nonenveloped viruses, including parvoviruses, influence tropism, host range, and pathogenicity by diverse mechanisms. In the MVM and the CPV/FPV systems, the determinants for host range and tropism are encoded within VP2 and map to the surface of the capsid (Ball-Goodrich and Chang et al., 1992; Gardiner and Tattersall, 1988; Parker and Parrish, 1998; Strassheim et al., 1994; Truyen and Parrish, 1992) ; however, the effect is exerted at an intracellular step after cell entry, before viral DNA amplification (Ball-Goodrich and Tattersall, 1992; Previsani et al., 1997) . Furthermore, in the case of CPV/FPV, the in vivo and in vitro host range determinants are distinct, yet both are controlled by the capsid proteins. In the TMEV system (Lipton and Jelachich, 1997) , it appears that a specific conformation of VP1 and VP2 influences persistence and pathogenicity by modulating virion binding to host cells. In the poliovirus system, the effect of capsid gene residues on host range and neuropathogenicity is complex (Colston and Racaniello, 1995; Couderc et al., 1996) , but it seems to involve modulation of receptor binding, changes in capsid conformation after binding, or both (Colston and Racaniello, 1995; Couderc et al., 1996; Murray et al., 1998) . A single amino acid in the VP1 capsid protein of coxsackievirus B4 influences how efficiently B and T cells are recruited to the pancreas of infected mice and consequently how much pancreatic destruction occurs (Ramsigh et al., 1997) . Finally, mutant residues in polyomavirus VP1 appear to enhance virus spread and pathogenicity by altering the surface conformation of the virion and lowering the affinity of the virus for its receptor (Bauer et al., 1995; Dubensky et al., 1991; Freund et al., 1991) . Thus it is clear that there a number of potential avenues by which capsid proteins can influence the outcome of virus infection in vitro and in vivo. We intend to scrutinize ADV infections more precisely and elucidate which, if any, of these mechanisms are operational.
Our data suggest that G/U-8 was more pathogenic than G/U-10, although neither was as virulent as ADVUtah (Fig. 2) . This might have resulted from coding differences in the capsid sequence, and the VP2 gene of G/U-8 contains an additional ADV-Utah residue (valine 352) not present in the G/U-10. However, G/U-8 also contains a short segment of the ADV-Utah left open reading frame that codes for NS1 . Although large portions of the ADV-Utah left open reading frame do not confer pathogenicity on constructs with ADV-G capsid regions, they might act in concert with ADV-Utah capsid sequences to accentuate pathogenicity or in vivo replication. The three amino acid differences between ADV-G and ADV-Utah in this NS1 section (MU 15±30) Gottschalk et al., 1994) do not reside in a well-characterized domain of the NS1 protein Legendre and Rommelaere, 1992; Skiadopoulos et al., 1992; Vanacker and Rommelaere, 1995) . However, uncharacterized noncoding sequences in this section affect both the constitutive and the trans-activated activity of the ADV P36 capsid protein promoter . Although no experiments have compared the ADV-G and ADV-Utah promoters, differences between G/U-8 and G/U-10 may be a consequence of relative promoter function. In this regard, there is precedent for determinants of parvoviral host range residing in the nonstructural region (Brownstein et al., 1992; Naeger et al., 1990; Vasudevacharya and Compans, 1992) . Construction of additional chimeras and comparisons of the ADV-G and ADV-Utah promoters will be required to examine this possibility.
In summary, molecular clones of ADV were generated that both replicated in cell culture and caused AD in adult mink. Pathogenicity as well as in vitro replication competence appeared to be related to short sequences in the capsid protein gene. These new constructions will provide useful tools both in the fine mapping of viral determinants of pathogenicity and in the analysis of viral pathogenesis.
MATERIALS AND METHODS

Cells and viruses
The molecularly cloned ADV-G (XXI-Q-3±15) and other replication competent chimeric viruses were propagated and assayed in CRFK as described previously (Bloom et al., 1990 . In vivo propagation and assay of ADVUtah in adult Aleutian genotype (Sapphire) or mink kits have also been described (Oie et al., 1996) .
Molecular cloning techniques
Standard techniques were used for molecular cloning, DNA sequencing, restriction enzyme digestion, agarose gel electrophoresis and plasmid preparation (Bloom et al., , 1990 Oie et al., 1996) . Full-length molecular clones were transformed into and amplified in Escherichia coli JC8111 (recBCsbcrecF) (Bloom et al., 1990; Boissy and Astell, 1985) . Other plasmids were maintained in E. coli JM109 (Yanisch-Perron et al., 1985) . The structures and the successful maintenance of the unstable right-hand (MU 100) hairpin were confirmed by restriction enzyme analysis.
Chimeric molecular clones (denoted G/U) were constructed by substitution of ADV-Utah fragments into the ADV-G molecular clone (formerly denoted as XXI-Q-3±15) (Bloom et al., 1990 . Individual constructs and the segments that were ADV-Utah were G/U-1 (MU 7±94), G/U-2 (MU 15±88, formerly denoted as XX-B-1; , G/U-3 (MU 54±88), G/U-4 (MU 15±73), G/U-5 (MU 54±65, formerly denoted as XXII-K-1; Bloom et al., 1993) , G/U-6 (MU 15±54 and MU 65±88), G/U-7 (MU 65±88), G/U-8 (MU 15±30 and 69±88), G/U-9 (MU 65±73, formerly denoted as XVII-T-2±2; Bloom et al., 1993) , G/U-10 (MU 73±88), and G/U-11 (MU 30±54 and MU 65±69).
Plasmids for transfection were batch prepared using commercially available kits from Promega (Madison, WI) and stored in aliquots as ethanol precipitates. Immediately before use, the DNA was collected by centrifugation and resuspended in sterile deionized water, and the concentration was verified by agarose gel electrophoresis (Bloom et al., 1990 .
Individual 35-mm culture dishes of CRFK cells were transfected with 5 g of purified plasmid DNA and incubated for 5 days at 31.8°C (Bloom et al., 1990 . Cell pellets were collected in 1 ml of medium, freeze-thawed, sonicated, and blindly passaged five times in cultures of CRFK before assay . To assess the ability of the recombinant plasmids to induce viral antigens, transfections with 1 g of plasmid were performed in four-well Labtek chambers . At the time of harvest, the specimens were fixed in acetone and stained for ADV antigens as described. As in previous work , all recombinant ADV plasmids, whether ultimately viable or not in CRFK cells, induced ADV antigens after primary transfection.
In vivo infectivity and pathogenicity
Adult Sapphire (Aleutian genotype) mink (Mustela vison) from an ADV-negative farm were housed in sheds in modified primate cages as reported previously (Oie et al., 1996) . All work involving animals was performed under supervision of the Rocky Mountain Laboratories Animal Care and Use Committee, and experimental manipulations were carried out under ketamine±acepromazine anesthesia.
After the collection of a preinoculation serum sample, groups of mink were inoculated intraperitoneally with 0.5 ml containing 10 5 FFU of ADV-G (Bloom et al., 1980 ) and viable chimeric viruses or 10 5 50% mink infectious doses of ADV-Utah Oie et al., 1996) . Control mink were inoculated with 0.5 ml of diluent. Animals were bled immediately before infection and at 10, 30, 60, and 90 days after inoculation. Serum samples were obtained by jugular venipuncture into Vacutainer Plus plastic centrifuge tubes containing SST gel and Clot Activator (Becton-Dickinson). Mink infected with the highly pathogenic ADV-Utah were maintained in a separate shed.
Serological response to ADV infection was assessed by counterimmune electrophoresis and determination of the percent serum ␥-globulin level by serum protein electrophoresis Eklund et al., 1968 ) using a horizontal thinlayer agarose gel system (Ciba-Corning). The increase in the percent ␥-globulin between the prebleeding and 90 days p.i. bleeding samples was determined using laser densitometry.
The presence of viremia was determined by performing a PCR assay on heat-treated serum Oie et al., 1996) . This method, amplifying a 692-bp fragment (MU 54.47±68.49, ADV-G nucleotides 2587±3279), can detect Ͻ1 fg (Ͻ10 genomes) in 2.5 l, the equivalent of Ͻ4000 genomes per milliliter of serum (Oie et al., 1996) . The use of PCR to detect viremia is ϳ100-fold more sensitive than the dot-blot method used previously . Controls and precautions used for this technique have been reported in detail Oie et al., 1996) .
Paraffin sections from blocks of liver, spleen, kidney, and mesenteric lymph node, collected at necropsy, were prepared and stained with hematoxylin±eosin according to standard histological procedures. Specimens were blindly evaluated for the presence of microscopic lesions characteristic of progressive AD (Eklund et al., 1968; Hadlow, 1994; Helmboldt and Jungherr, 1958) .
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